Chronic Kidney Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have high blood pressure that remains uncontrolled despite taking three different types of blood pressure medications, confirmed by a 24-hour blood pressure monitoring test showing readings above the thresholds set by current guidelines.
- People who have end-stage kidney disease and are receiving regular dialysis (hemodialysis) to manage their condition.
- People who have been on a stable dialysis schedule for at least 3 months, as determined by their treating doctor.
- People who have been taking the same medications without any changes for at least 4 weeks.
- People who are 18 years of age or older; both men and women are included.
Who may not be able to join:
- People who have episodes of low blood pressure (shown by 24-hour monitoring or dialysis records) that their doctor believes would make the procedure unsafe.
- People who have a known significant blockage or structural problem in the arteries leading to their kidneys that could make it unsafe to insert the required medical catheter.
- People who have previously had a renal denervation procedure (a treatment targeting the nerves around the kidney arteries).
- People who have only one functioning kidney, or who have received a kidney transplant.
- People who have severe artery hardening or calcium build-up that would prevent reliable blood pressure readings being obtained.
- People whose high blood pressure is caused by a hormonal condition, other than sleep apnea.
- People who have had a heart attack, severe chest pain (unstable angina), or stroke within the 3 months before the study screening visit.
- People who have had a recent flare-up of a systemic or kidney disease requiring an increase in immune-suppressing medication within the last 3 months.
- People who are pregnant, breastfeeding, or planning to become pregnant.
- People who are already enrolled in another interventional research study.
- People who have any other condition that, in the opinion of the study investigator, would prevent safe or reliable participation in the trial (for example, difficulty following medical instructions).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +49 9131 8536207
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Safety endpoints and adverse effects; Change in 24-h ambulatory systolic blood pressure between baseline and 3 months post-procedure
Can't join this trial?
Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.